{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:38:00Z","timestamp":1787017080276,"version":"build-2736575974"},"reference-count":79,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,1,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The 2025 British Thoracic Society (BTS) Winter Meeting delivered 3\u2009days of cutting-edge science, clinical innovation and networking in wintry Westminster. Over 2500 attendees from 36 countries gathered to share advances shaping the future of respiratory medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>The programme opened with a session focused on emerging clinical trial data, showcasing pragmatic and mechanistic studies designed to address real-world challenges in respiratory care, setting the tone for a meeting focused on impact and innovation.<\/jats:p>\n                    <jats:p>Translational research featured strongly throughout the meeting, with organoids, precision-cut lung slices and air-liquid interface cultures providing new perspectives on disease mechanisms and therapeutic targets. Early career investigators presented discoveries in eosinophilic chronic obstructive pulmonary disease biology, microbiome-driven viral susceptibility and resistance risks in novel bronchiectasis therapies, while midcareer leaders advanced understanding of familial interstitial lung disease and virus\u2013host interactions.<\/jats:p>\n                    <jats:p>Plenary sessions tackled pressing challenges, from air pollution and breathlessness diagnostics to genetic drivers of pulmonary hypertension, complemented by guest lectures on immune regulation, vaccine-preventable illness and drug discovery. Additionally, the meeting highlighted workforce transformation, emphasising the role of nurses, allied health professionals and pharmacists in delivering integrated, digitally enabled care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Reminding us that progress rests on both scientific endeavour and enduring professional bonds, the 2025 BTS Winter Meeting reaffirmed that respiratory research is for everyone\u2014an essential driver of advancement across disciplines. Multidisciplinary working and inclusive engagement will be key to shaping future care and ensuring that innovation translates into better outcomes for patients worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2025-224712","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:21:46Z","timestamp":1770747706000},"page":"thorax-2025-224712","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Review of the British Thoracic Society Winter Meeting 26\u201329 November 2025"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9326-966X","authenticated-orcid":false,"given":"Cara A","family":"Flynn","sequence":"first","affiliation":[{"name":"Respiratory Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra (Ola)","family":"Howell","sequence":"additional","affiliation":[{"name":"University of Oxford Nuffield Department of Primary Care Health Sciences, Oxford, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Howell","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, University of Oxford Nuffield Department of Medicine, Oxford, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital NHS Foundation Trust, University of Cambridge, Cambridge, UK, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mwasuku","sequence":"additional","affiliation":[{"name":"King's Centre for Lung Health, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Bafadhel","sequence":"additional","affiliation":[{"name":"King's Centre for Lung Health, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-6500","authenticated-orcid":false,"given":"Nicholas A","family":"Maskell","sequence":"additional","affiliation":[{"name":"North Bristol Lung Centre, Southmead Hospital, Bristol, England, UK"},{"name":"University of Bristol Academic Respiratory Unit, Bristol, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-7201","authenticated-orcid":false,"given":"Richard EK","family":"Russell","sequence":"additional","affiliation":[{"name":"King's Centre for Lung Health, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026021010213873000_thorax-2025-224712v1.1","article-title":"S1 Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO","volume":"80","author":"Greening","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.2","unstructured":"Genentech I . Genentech provides update on astegolimab in chronic obstructive pulmonary disease. 2025. Available: https:\/\/www.gene.com\/media\/press-releases\/15071\/2025-07-20\/genentech-provides-update-on-astegolimab"},{"key":"2026021010213873000_thorax-2025-224712v1.3","doi-asserted-by":"crossref","unstructured":"Hill A , Lewis S , Tuck S , et al . S2 What is the clinical effectiveness and cost-effectiveness of nebulised 7% saline in patients with chronic obstructive pulmonary disease (COPD)- (MucAct COPD Trial). Thorax 2025;A7\u20138. doi:10.1136\/thorax-2025-BTSabstracts.8","DOI":"10.1136\/thorax-2025-BTSabstracts.8"},{"key":"2026021010213873000_thorax-2025-224712v1.4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04042-2020","article-title":"The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation","volume":"58","author":"Hartley","year":"2021","journal-title":"Eur Respir J"},{"key":"2026021010213873000_thorax-2025-224712v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.9"},{"key":"2026021010213873000_thorax-2025-224712v1.6","doi-asserted-by":"crossref","unstructured":"Linden DA , Dorrian D , Glenn M , et al . S4\u2005effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (hipi): a randomised, double-blind, placebo-controlled trial. British Thoracic Society Winter Meeting 2025, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 26 to 28 November 2025, Programme and Abstracts; November 2025 doi:10.1136\/thorax-2025-BTSabstracts.10","DOI":"10.1136\/thorax-2025-BTSabstracts.10"},{"key":"2026021010213873000_thorax-2025-224712v1.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088490","article-title":"HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE\u00ae FILM ARRAY\u00ae pneumonia plus panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia","volume":"14","author":"Shafiqa","year":"2024","journal-title":"BMJ Open"},{"key":"2026021010213873000_thorax-2025-224712v1.8","doi-asserted-by":"crossref","unstructured":"Wootton D , Powell I , Willshaw S , et al . S5\u2005HAP-fast: a pilot sequential multiple assignment randomised trial (smart) comparing chest x-ray to low-dose ct scan and empirical antibiotics to antibiotics guided by the biofire\u00ae film array\u00ae pneumonia plus panel in adults with suspected non-ventilator-associated hospital-acquired pneumonia. British Thoracic Society Winter Meeting 2025, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 26 to 28 November 2025, Programme and Abstracts; November 2025:A9\u201310. doi:10.1136\/thorax-2025-BTSabstracts.11","DOI":"10.1136\/thorax-2025-BTSabstracts.11"},{"key":"2026021010213873000_thorax-2025-224712v1.9","article-title":"S6 Conservative management in traumatic pneumothoraces in the emergency department (CoMiTED): a randomised controlled trial","volume":"80","author":"Annaw","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.10","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222086"},{"key":"2026021010213873000_thorax-2025-224712v1.11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(25)00082-8","article-title":"Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study","volume":"26","author":"Bhamani","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026021010213873000_thorax-2025-224712v1.12","doi-asserted-by":"crossref","unstructured":"Jackson DJ , Lugogo NL , Gurnell M , et al . Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial. Lancet Respir Med 2025. doi:10.1016\/S2213-2600(25)00359-5","DOI":"10.1016\/S2213-2600(25)00359-5"},{"key":"2026021010213873000_thorax-2025-224712v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2022.11.013"},{"key":"2026021010213873000_thorax-2025-224712v1.14","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.stem.2025.09.007","article-title":"Hypoxia promotes airway differentiation in the human lung epithelium","volume":"32","author":"Dong","year":"2025","journal-title":"Cell Stem Cell"},{"key":"2026021010213873000_thorax-2025-224712v1.15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s44318-024-00328-6","article-title":"A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease","volume":"44","author":"Lim","year":"2025","journal-title":"EMBO J"},{"key":"2026021010213873000_thorax-2025-224712v1.16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00455-2020","article-title":"Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia","volume":"58","author":"Lee","year":"2021","journal-title":"Eur Respir J"},{"key":"2026021010213873000_thorax-2025-224712v1.17","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.263487","article-title":"Compound screening in human airway basal cells identifies Wnt pathway activators as potential pro-regenerative therapies","volume":"138","author":"Ishii","year":"2025","journal-title":"J Cell Sci"},{"key":"2026021010213873000_thorax-2025-224712v1.18","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0247OC"},{"key":"2026021010213873000_thorax-2025-224712v1.19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1165\/rcmb.2021-0544OC","article-title":"Calcium-Sensing Receptor Negative Allosteric Modulators Oppose Contraction of Mouse Airways","volume":"69","author":"Diao","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021010213873000_thorax-2025-224712v1.20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S2213-2600(18)30196-6","article-title":"Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study","volume":"6","author":"Koo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026021010213873000_thorax-2025-224712v1.21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201811-2083OC","article-title":"Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease","volume":"200","author":"Vasilescu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021010213873000_thorax-2025-224712v1.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202303-0534OC"},{"key":"2026021010213873000_thorax-2025-224712v1.23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18555-9","article-title":"A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis","volume":"8","author":"Roach","year":"2018","journal-title":"Sci Rep"},{"key":"2026021010213873000_thorax-2025-224712v1.24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.679388"},{"key":"2026021010213873000_thorax-2025-224712v1.25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","article-title":"Local and systemic responses to SARS-CoV-2 infection in children and adults","volume":"602","author":"Yoshida","year":"2022","journal-title":"Nature New Biol"},{"key":"2026021010213873000_thorax-2025-224712v1.26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41564-024-01658-1","article-title":"Age-specific nasal epithelial responses to SARS-CoV-2 infection","volume":"9","author":"Woodall","year":"2024","journal-title":"Nat Microbiol"},{"key":"2026021010213873000_thorax-2025-224712v1.27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jleuko\/qiad011","article-title":"Trans-epithelial migration is essential for neutrophil activation during RSV infection","volume":"113","author":"Robinson","year":"2023","journal-title":"J Leukoc Biol"},{"key":"2026021010213873000_thorax-2025-224712v1.28","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220081"},{"key":"2026021010213873000_thorax-2025-224712v1.29","article-title":"T3 Lung eosinophils in eosinophilic COPD patients differ functionally but not phenotypically","volume":"80","author":"Cass","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.30","article-title":"T1 Retrospective evaluation of artificial intelligence (AI) software for the detection of acute pulmonary embolism (PE) in CT pulmonary angiograms (CTPA): a preliminary ground-truth analysis from the AID-PE study","volume":"80","author":"Page","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.31","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A3117","article-title":"A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)","volume":"211","author":"Long","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021010213873000_thorax-2025-224712v1.32","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.5"},{"key":"2026021010213873000_thorax-2025-224712v1.33","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.4"},{"key":"2026021010213873000_thorax-2025-224712v1.34","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.1"},{"key":"2026021010213873000_thorax-2025-224712v1.35","article-title":"T5 Reduced airway remodelling and increased epithelial barrier integrity in bronchial biopsies from patients with T2 high severe asthma following mepolizumab treatment","volume":"80","author":"Drummond","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01383-2022"},{"key":"2026021010213873000_thorax-2025-224712v1.37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00267-2021","article-title":"Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant","volume":"59","author":"Dickens","year":"2022","journal-title":"Eur Respir J"},{"key":"2026021010213873000_thorax-2025-224712v1.38","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8030106","article-title":"Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection","volume":"8","author":"Glaser","year":"2019","journal-title":"Pathogens"},{"key":"2026021010213873000_thorax-2025-224712v1.39","doi-asserted-by":"crossref","unstructured":"Broadbent L , Roberts GC , Coey JD , et al . Inhibition of the tlr4 signalling pathway with tak-242 reduces rsv infection and cytokine release in primary airway epithelial cells. Microbiology [Preprint]. doi:10.1101\/2021.11.22.469503","DOI":"10.1101\/2021.11.22.469503"},{"key":"2026021010213873000_thorax-2025-224712v1.40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.12968\/pnur.2025.0012","article-title":"Nurses and smoking: barriers and support for quitting","volume":"36","author":"Donovan","year":"2025","journal-title":"Practice Nursing"},{"key":"2026021010213873000_thorax-2025-224712v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfv034"},{"key":"2026021010213873000_thorax-2025-224712v1.42","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222795"},{"key":"2026021010213873000_thorax-2025-224712v1.43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002716","article-title":"Investigating a structured diagnostic approach for chronic breathlessness in primary care: a mixed-methods feasibility cluster randomised controlled trial","volume":"12","author":"Doe","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"2026021010213873000_thorax-2025-224712v1.44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.061940"},{"key":"2026021010213873000_thorax-2025-224712v1.45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.medj.2021.03.013","article-title":"Alterations in T and B cell function persist in convalescent COVID-19 patients","volume":"2","author":"Shuwa","year":"2021","journal-title":"Med"},{"key":"2026021010213873000_thorax-2025-224712v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00850-X"},{"key":"2026021010213873000_thorax-2025-224712v1.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213836"},{"key":"2026021010213873000_thorax-2025-224712v1.48","doi-asserted-by":"crossref","first-page":"106570","DOI":"10.1016\/j.jinf.2025.106570","article-title":"Burden of respiratory syncytial virus infection in older adults hospitalised in England during 2023\/24","volume":"91","author":"Symes","year":"2025","journal-title":"J Infect"},{"key":"2026021010213873000_thorax-2025-224712v1.49","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2216480"},{"key":"2026021010213873000_thorax-2025-224712v1.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110275"},{"key":"2026021010213873000_thorax-2025-224712v1.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2214773"},{"key":"2026021010213873000_thorax-2025-224712v1.52","doi-asserted-by":"crossref","first-page":"126948","DOI":"10.1016\/j.vaccine.2025.126948","article-title":"Cost-effectiveness of routine COVID-19 adult vaccination programmes in England","volume":"53","author":"Keeling","year":"2025","journal-title":"Vaccine (Auckl)"},{"key":"2026021010213873000_thorax-2025-224712v1.53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-2600(13)70187-5","article-title":"Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials","volume":"1","author":"Franciosi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026021010213873000_thorax-2025-224712v1.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-0944OC"},{"key":"2026021010213873000_thorax-2025-224712v1.55","doi-asserted-by":"crossref","first-page":"102365","DOI":"10.1016\/j.pupt.2025.102365","article-title":"Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial","volume":"90","author":"Hohlfeld","year":"2025","journal-title":"Pulm Pharmacol Ther"},{"key":"2026021010213873000_thorax-2025-224712v1.56","article-title":"S57 EP395, a novel non-antibiotic macrolide, enhances antiviral responses in bronchial epithelial cells from asthma patients","volume":"80","author":"Malm Tillgren","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.57","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.122.000684"},{"key":"2026021010213873000_thorax-2025-224712v1.58","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03148-2","article-title":"Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence","volume":"24","author":"van Haren","year":"2020","journal-title":"Crit Care"},{"key":"2026021010213873000_thorax-2025-224712v1.59","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103339","article-title":"Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studies","volume":"88","author":"van Haren","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026021010213873000_thorax-2025-224712v1.60","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-224029"},{"key":"2026021010213873000_thorax-2025-224712v1.61","unstructured":"Health Innovation Oxford & Thames Valley . The respiratory transformation partnership. 2025. Available: https:\/\/www.healthinnovationoxford.org\/clinical-priorities\/respiratory\/the-respiratory-transformation-partnership\/"},{"key":"2026021010213873000_thorax-2025-224712v1.62","article-title":"S43 Longitudinal trends in asthma mortality and life-threatening asthma in children in England","volume":"80","author":"Gawlik-Lipinski","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.63","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.245"},{"key":"2026021010213873000_thorax-2025-224712v1.64","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.254"},{"key":"2026021010213873000_thorax-2025-224712v1.65","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.418"},{"key":"2026021010213873000_thorax-2025-224712v1.66","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.512"},{"key":"2026021010213873000_thorax-2025-224712v1.67","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.302"},{"key":"2026021010213873000_thorax-2025-224712v1.68","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.132"},{"key":"2026021010213873000_thorax-2025-224712v1.69","first-page":"A9","article-title":"S7 Predicting outcomes from acute exacerbations of interstitial lung disease: a multicentre observational study","volume":"80","author":"Goodwin","year":"2023","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.70","article-title":"S17 Low serum testosterone predicts survival in patients in fibrotic interstitial lung disease: longitudinal follow-up of the STARSHIP cohort","volume":"80","author":"Goodrum","year":"2025","journal-title":"Thorax"},{"key":"2026021010213873000_thorax-2025-224712v1.71","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.128"},{"key":"2026021010213873000_thorax-2025-224712v1.72","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.41"},{"key":"2026021010213873000_thorax-2025-224712v1.73","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01295-2023","article-title":"PET-CT-guided versus CT-guided biopsy in suspected malignant pleural thickening: a randomised trial","volume":"63","author":"de Fonseka","year":"2024","journal-title":"Eur Respir J"},{"key":"2026021010213873000_thorax-2025-224712v1.74","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-BTSabstracts.186"},{"key":"2026021010213873000_thorax-2025-224712v1.75","doi-asserted-by":"crossref","unstructured":"Aung HWW , Vermeersch K , McAuley HJC , et al . Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) model. Lancet Respir Med 2025. doi:10.1016\/S2213-2600(25)00362-5","DOI":"10.1016\/S2213-2600(25)00362-5"},{"key":"2026021010213873000_thorax-2025-224712v1.76","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.49234","article-title":"Implementation of a Metered-Dose Inhaler to Dry-Powder Inhaler National Formulary Transition","volume":"7","author":"Rabin","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026021010213873000_thorax-2025-224712v1.77","doi-asserted-by":"crossref","first-page":"e1423","DOI":"10.1016\/S2214-109X(22)00330-8","article-title":"The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review","volume":"10","author":"Stolbrink","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026021010213873000_thorax-2025-224712v1.78","unstructured":"Royal College of Physicians . A breath of fresh air: responding to the health challenges of modern air pollution. 2025."},{"key":"2026021010213873000_thorax-2025-224712v1.79","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220877"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-224712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:21:51Z","timestamp":1770747711000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-224712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":79,"alternative-id":["10.1136\/thorax-2025-224712"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-224712","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}